Biodexa Pharmaceuticals Plc

(NASDAQ) BDRX

Current Price$3.59

Market Cap$1.68M

Since IPO (2015)-100%

5 Year-100%

1 Year-94%

1 Month+20%

Biodexa Pharmaceuticals Plc Financials at a Glance

Market Cap

$1.68M

Revenue (TTM)

$0.00

Net Income (TTM)

$12.10M

EPS (TTM)

$-103.95

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$3.59

Volume

537

Open

$3.58

Price

$3.59

Volume

537

Open

$3.58

Previous Close

$3.59

Daily Range

$3.57 - $3.59

52-Week Range

$2.86 - $96.50

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$3.59

Volume

537

Open

$3.58

Previous Close

$3.59

Daily Range

$3.57 - $3.59

52-Week Range

$2.86 - $96.50

BDRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biodexa Pharmaceuticals Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stephen Anthony Stamp

Website

www.biodexapharma.com

Headquarters

Cardiff, CF10 4DQ, GB

BDRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-65%

Return on Capital

-73%

Return on Assets

-35%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.68M

Shares Outstanding

451.60K

Volume

537

Avg. Volume

766.49K

Financials (TTM)

Gross Profit

$184.86K

Operating Income

$8.27M

EBITDA

$8.08M

Operating Cash Flow

$5.39M

Capital Expenditure

$1.96K

Free Cash Flow

$5.40M

Cash & ST Invst.

$8.52M

Total Debt

$60.89K

Biodexa Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$48.70K

+97.8%

Gross Margin

0.00%

N/A

Market Cap

$1.68M

N/A

Market Cap/Employee

$129.06K

N/A

Employees

N/A

Net Income

$2.56M

+27.0%

EBITDA

$4.68M

-104.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$8.46M

+53.6%

Accounts Receivable

$221.61K

-68.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$60.89K

-64.0%

Return on Assets

-35.09%

N/A

Return on Invested Capital

-72.66%

N/A

Free Cash Flow

$2.33M

+21.6%

Operating Cash Flow

$2.33M

+21.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNPXGenprex, Inc.

GNPXGenprex, Inc.$0.86+1.20%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$0.65+2.54%

CNSPCNS Pharmaceuticals, Inc.

CNSPCNS Pharmaceuticals, Inc.$5.01-9.24%

JAGXJaguar Health, Inc.

JAGXJaguar Health, Inc.$3.94+18.32%

GRIGRI Bio, Inc.

GRIGRI Bio, Inc.$2.15-3.59%

GLMDGalmed Pharmaceuticals Ltd.

GLMDGalmed Pharmaceuticals Ltd.$0.66+10.62%

BIVIBioVie Inc.

BIVIBioVie Inc.$1.38+5.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

NOKNokia

NOKNokia$14.46-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

CSCOCisco Systems

CSCOCisco Systems$115.53+0.13%

SOFISoFi Technologies

SOFISoFi Technologies$16.02+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.70-0.00%

IRENIren

IRENIren$58.40+0.06%

Questions About BDRX

What is the current price of Biodexa Pharmaceuticals Plc?

Biodexa Pharmaceuticals Plc is trading at $3.59 per share.

What is the 52-week range for Biodexa Pharmaceuticals Plc?

Over the past 52 weeks, Biodexa Pharmaceuticals Plc has traded between $2.86 and $96.50.

How much debt does Biodexa Pharmaceuticals Plc have?

As of the most recent reporting period, Biodexa Pharmaceuticals Plc reported total debt of $82,048.05.

How much cash does Biodexa Pharmaceuticals Plc have on hand?

Biodexa Pharmaceuticals Plc reported $11.48M in cash and cash equivalents in its most recent financial results.

What is Biodexa Pharmaceuticals Plc’s dividend yield?

Biodexa Pharmaceuticals Plc does not currently have a dividend yield.

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc Financials at a Glance

BDRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biodexa Pharmaceuticals Plc

BDRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biodexa Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BDRX

What is the current price of Biodexa Pharmaceuticals Plc?

What is the 52-week range for Biodexa Pharmaceuticals Plc?

How much debt does Biodexa Pharmaceuticals Plc have?

How much cash does Biodexa Pharmaceuticals Plc have on hand?

What is Biodexa Pharmaceuticals Plc’s dividend yield?

Premium Investing Services